GoodRx Holdings, Inc. (NASDAQ: GDRX) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $1.2B. The Maz Rating grades it against the other companies in its sector.
GoodRx Holdings, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $3.47, GoodRx Holdings, Inc. trades at 66.6x trailing earnings, 1.5x sales and 1.8x book value, with an EV/EBITDA of 8.3. Over the last twelve months it generated about $777M of revenue and $18M of net income. It runs a gross margin of 88.1%, an operating margin of 10.2% and a net margin of 2.1%. It shows return on equity of 2.6%, return on invested capital of 2.6% and a free cash flow yield of 12.3%. On the balance sheet: a debt-to-equity ratio of 0.83 and a current ratio of 1.38. Over the past 52 weeks the share price ranged from $1.77 to $3.89, with a beta of 1.67.
GoodRx Holdings, Inc. does not currently pay a dividend.
24 Wall Street analyst ratings cover the stock: 9 Buy, 13 Hold and 2 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.